Use of direct oral anticoagulants does not significantly increase delayed bleeding after endoscopic submucosal dissection for early gastric neoplasms

Abstract Direct oral anticoagulants (DOACs) are widely prescribed for the prevention of stroke in elderly patients with atrial fibrillation and approved indication for DOAC has been expanded. We aimed to evaluate the risk of delayed bleeding in patients who had taken DOAC and underwent endoscopic su...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jinju Choi, Soo-Jeong Cho, Sang-Hoon Na, Ayoung Lee, Jue Lie Kim, Hyunsoo Chung, Sang Gyun Kim
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/bd1a9ad47b8242728d542dd41170e145
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bd1a9ad47b8242728d542dd41170e145
record_format dspace
spelling oai:doaj.org-article:bd1a9ad47b8242728d542dd41170e1452021-12-02T17:15:33ZUse of direct oral anticoagulants does not significantly increase delayed bleeding after endoscopic submucosal dissection for early gastric neoplasms10.1038/s41598-021-88656-z2045-2322https://doaj.org/article/bd1a9ad47b8242728d542dd41170e1452021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88656-zhttps://doaj.org/toc/2045-2322Abstract Direct oral anticoagulants (DOACs) are widely prescribed for the prevention of stroke in elderly patients with atrial fibrillation and approved indication for DOAC has been expanded. We aimed to evaluate the risk of delayed bleeding in patients who had taken DOAC and underwent endoscopic submucosal dissection (ESD) for gastric neoplasms. We included consecutive patients who underwent ESD between January 2016 and July 2019 in Seoul National University Hospital. Patients were divided into four groups (no med; no medication, DOAC, WFR; warfarin, anti-PLT; anti-platelet agent) according to the medications they had been taken before the procedure. We defined delayed bleeding as obvious post-procedural gastrointestinal bleeding sign including hematemesis or melena combined with hemoglobin drop ≥ 2 g/dL. Among 1634 patients enrolled in this study, 23 (1.4%) patients had taken DOAC and they usually stopped the medication for 2 days before the ESD and resumed within 1 or 2 days. We compared rates of delayed bleeding between groups. Delayed bleeding rates of the groups of no med, DOAC, WFR, and anti-PLT were 2.1% (32/1499) 8.7% (2/23), 14.3% (2/14), 11.2% (11/98), respectively (P < 0.001). However, there was no difference of delayed bleeding rate between no med and DOAC group after propensity score matching (no med vs DOAC, 1.7% vs 10.0%, P = 0.160). Taking DOAC was not associated statistically with post-ESD bleeding when adjusted by age, sex, comorbidities and characteristics of target lesion (Adjusted Odds Ratio: 2.4, 95% Confidence intervals: 0.41–13.73, P = 0.335). Crude rate of bleeding in DOAC users seemed to be higher than no medication group after performing ESD with 2 days of medication cessation. When adjusted by age, sex, and comorbidity, however, this difference seems to be small, which suggests that gastric post-ESD bleeding may be influenced by patients’ underlying condition in addition to medication use.Jinju ChoiSoo-Jeong ChoSang-Hoon NaAyoung LeeJue Lie KimHyunsoo ChungSang Gyun KimNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jinju Choi
Soo-Jeong Cho
Sang-Hoon Na
Ayoung Lee
Jue Lie Kim
Hyunsoo Chung
Sang Gyun Kim
Use of direct oral anticoagulants does not significantly increase delayed bleeding after endoscopic submucosal dissection for early gastric neoplasms
description Abstract Direct oral anticoagulants (DOACs) are widely prescribed for the prevention of stroke in elderly patients with atrial fibrillation and approved indication for DOAC has been expanded. We aimed to evaluate the risk of delayed bleeding in patients who had taken DOAC and underwent endoscopic submucosal dissection (ESD) for gastric neoplasms. We included consecutive patients who underwent ESD between January 2016 and July 2019 in Seoul National University Hospital. Patients were divided into four groups (no med; no medication, DOAC, WFR; warfarin, anti-PLT; anti-platelet agent) according to the medications they had been taken before the procedure. We defined delayed bleeding as obvious post-procedural gastrointestinal bleeding sign including hematemesis or melena combined with hemoglobin drop ≥ 2 g/dL. Among 1634 patients enrolled in this study, 23 (1.4%) patients had taken DOAC and they usually stopped the medication for 2 days before the ESD and resumed within 1 or 2 days. We compared rates of delayed bleeding between groups. Delayed bleeding rates of the groups of no med, DOAC, WFR, and anti-PLT were 2.1% (32/1499) 8.7% (2/23), 14.3% (2/14), 11.2% (11/98), respectively (P < 0.001). However, there was no difference of delayed bleeding rate between no med and DOAC group after propensity score matching (no med vs DOAC, 1.7% vs 10.0%, P = 0.160). Taking DOAC was not associated statistically with post-ESD bleeding when adjusted by age, sex, comorbidities and characteristics of target lesion (Adjusted Odds Ratio: 2.4, 95% Confidence intervals: 0.41–13.73, P = 0.335). Crude rate of bleeding in DOAC users seemed to be higher than no medication group after performing ESD with 2 days of medication cessation. When adjusted by age, sex, and comorbidity, however, this difference seems to be small, which suggests that gastric post-ESD bleeding may be influenced by patients’ underlying condition in addition to medication use.
format article
author Jinju Choi
Soo-Jeong Cho
Sang-Hoon Na
Ayoung Lee
Jue Lie Kim
Hyunsoo Chung
Sang Gyun Kim
author_facet Jinju Choi
Soo-Jeong Cho
Sang-Hoon Na
Ayoung Lee
Jue Lie Kim
Hyunsoo Chung
Sang Gyun Kim
author_sort Jinju Choi
title Use of direct oral anticoagulants does not significantly increase delayed bleeding after endoscopic submucosal dissection for early gastric neoplasms
title_short Use of direct oral anticoagulants does not significantly increase delayed bleeding after endoscopic submucosal dissection for early gastric neoplasms
title_full Use of direct oral anticoagulants does not significantly increase delayed bleeding after endoscopic submucosal dissection for early gastric neoplasms
title_fullStr Use of direct oral anticoagulants does not significantly increase delayed bleeding after endoscopic submucosal dissection for early gastric neoplasms
title_full_unstemmed Use of direct oral anticoagulants does not significantly increase delayed bleeding after endoscopic submucosal dissection for early gastric neoplasms
title_sort use of direct oral anticoagulants does not significantly increase delayed bleeding after endoscopic submucosal dissection for early gastric neoplasms
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/bd1a9ad47b8242728d542dd41170e145
work_keys_str_mv AT jinjuchoi useofdirectoralanticoagulantsdoesnotsignificantlyincreasedelayedbleedingafterendoscopicsubmucosaldissectionforearlygastricneoplasms
AT soojeongcho useofdirectoralanticoagulantsdoesnotsignificantlyincreasedelayedbleedingafterendoscopicsubmucosaldissectionforearlygastricneoplasms
AT sanghoonna useofdirectoralanticoagulantsdoesnotsignificantlyincreasedelayedbleedingafterendoscopicsubmucosaldissectionforearlygastricneoplasms
AT ayounglee useofdirectoralanticoagulantsdoesnotsignificantlyincreasedelayedbleedingafterendoscopicsubmucosaldissectionforearlygastricneoplasms
AT jueliekim useofdirectoralanticoagulantsdoesnotsignificantlyincreasedelayedbleedingafterendoscopicsubmucosaldissectionforearlygastricneoplasms
AT hyunsoochung useofdirectoralanticoagulantsdoesnotsignificantlyincreasedelayedbleedingafterendoscopicsubmucosaldissectionforearlygastricneoplasms
AT sanggyunkim useofdirectoralanticoagulantsdoesnotsignificantlyincreasedelayedbleedingafterendoscopicsubmucosaldissectionforearlygastricneoplasms
_version_ 1718381282567651328